Puma Breast Cancer Drug Shows Success in Trial

World News: . []

Puma Biotechnology’s flagship drug has been shown to reduce the risk of breast cancer, recurring disease or death in women who have taken it five years, according to a new study.

Read More: http://labusinessjournal.com/news/2017/nov/14/puma-breast-cancer-drug-shows-success-trial/

Published: .

Search for other references to "puma" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us